The frequency of MTHFR C677T polymorphism in chronic kidney disease
DOI: https://doi.org/10.29296/25877305-2019-05-03
Issue:
5
Year:
2019
The role of methylenetetrahydrofolate reductase (MTHFR) gene mutation in the progression of chronic glomerulonephritis was investigated. MTHFR C677T polymorphism was evaluated by polymerase chain reaction-restriction analysis of the amplified DNA fragments. The paper shows the prevalence of polymorphic variants in healthy individuals and patients with kidney diseases: 90 with different forms of chronic glomerulonephritis and 30 with chronic renal failure (CRF). MTHFR C677T polymorphism was found in 53% of patients with CRF (odds ratio (OR) = 1.66; p < 0.005) and in 31% of healthy individuals. There is a relationship between the MTHFR C677T polymorphism and the development of CRF.
Keywords:
nephrology
methylenetetrahydrofalate reductase
MTHFR C677T polymorphism
chronic glomerulonephritis
chronic renal failure
References:
- Barannikova E.I., Kozlovskaja N.L., Ponkina O.N. i dr. Geneticheskaja gipergomotsisteinemija kak prichina arterial'nyh i venoznyh trombozov u bol'nogo hronicheskim glomerulonefritom // Nefrologija i dializ. – 2008; 10 (3): 254–8 [Barannikova E.I., Kozlovskaja N.L., Ponkina O.N. et al. Genetic hyperhomocysteinemia as a cause of arterial and venous thrombosis in a patient with chronic glomerulonephritis // Nefrologija i dializ. – 2008; 10 (3): 254–8 (in Russ.)].
- Dobronravov V.A., Golubev R.V. Gipergomotsisteinemija – faktor riska serdechno-sosudistyh porazhenij u dializnyh bol'nyh i v obschej populjatsii // Nefrologija. – 2004; 8 (pril. 2): 44–9 [Dobronravov V.A., Golubev R.V. Hyperhomocysteinemia as a risk factor for cardiovascular lesions in dialysis patients and in the general population // Nefrologija. – 2004; 8 (pril. 2): 44–9 (in Russ.)].
- Kaljuzhin V.V., Urazova O.I., Kaljuzhina E.V. i dr. Nespetsificheskie mehanizmy progressirovanija hronicheskoj bolezni pochek // Bjulleten' sibirskoj meditsiny. – 2015; 14 (4): 87–98 [Kaljuzhin V.V., Urazova O.I., Kaljuzhina E.V. et al. Non-specific mechanisms for the progression of chronic kidney disease // Bjulleten’ sibirskoj mediciny. – 2015; 14 (4): 87–98 (in Russ.)].
- Sibireva O.F., Kaljuzhin V.V., Urazova O.I. i dr. Panel' laboratornyh markerov patologii gemostaza v prognozirovanii skorosti progressirovanija hronicheskoj bolezni pochek // Klin. nefrol. – 2012; 3: 13–6 [Sibireva O.F., Kaljuzhin V.V., Urazova O.I. et al. Panel of laboratory markers of hemostatic pathology in predicting the rate of progression of chronic kidney disease // Klin. nefrol. – 2012; 3: 13–6 (in Russ.)].
- Azarov V.V., Firsov N.N., Kozlovskaja L.V. i dr. Narushenie reologicheskih svojstv krovi u bol'nyh glomerulonefritami. 1 s'ezd nefrologov Rossii: Tezisy dokladov / Kazan', 1994; s. 5 [Azarov V.V., Firsov N.N., Kozlovskaja L.V. et al. Violation of the rheological properties of blood in patients with glomerulonephritis. 1 s’ezd nefrologov Rossii: Tezisy dokladov / Kazan’, 1994; p. 5 (in Russ.)].
- Shmakova N.A., Harina O.P., Ivanov S.N. i dr. Narushenie funktsii sosudistogo endotelija, sutochnogo profilja arterial'nogo davlenija i puti ih korrektsii u detej s glomerulonefritom. Nefrologicheskij seminar-2006: sb. trudov HIV ezhegodnogo Sankt-Peterburgskogo nefrologicheskogo seminara / SPb, 2006; s. 146–9 [Shmakova N.A., Harina O.P., Ivanov S.N. et al. Vascular endothelium functional failure, the daily blood pressure profile and ways to correct them in children with glomerulonephritis. Nefrologicheskij seminar-2006: sb. trudov XIV ezhegodnogo Sankt-Peterburgskogo nefrologicheskogo seminara / SPb., 2006; r. 146–9 (in Russ.)].
- Pavlenko O.A., Kolosovskaja T.A., Sibireva O.F. i dr. Rasprostranennost', klinicheskoe i prognosticheskoe znachenie polimorfizma genov II, V faktorov svertyvanija krovi i metilentetragidrofolatreduktazy u patsientov s hronicheskoj bolezn'ju pochek // Bjulleten' sibirskoj meditsiny. – 2009; 8 (4–2): 80–5 [Pavlenko O.A., Kolosovskaja T.A., Sibireva O.F. et al. Prevalence, clinical and prognostic significance of gene polymorphism II, V coagulation factors and methylene tetrahydrofolate reductase in patients with chronic kidney disease // Bjulleten’ sibirskoj mediciny. – 2009; 8 (4–2): 80–5 (in Russ.)].
- Sibireva O.F., Hitrinskaja E.Ju., Ivanchuk I.I. i dr. Geneticheskaja determinirovannost' povyshenija trombogennogo potentsiala krovi u bol'nyh hronicheskim glomerulonefritom // Nefrologija. – 2008; 12 (2): 52–5 [Sibireva O.F., Hitrinskaja E.Ju., Ivanchuk I.I. et al. Genetic determinism increase in blood thrombogenic potential in patients with chronic glomerulonephritis // Nefrologija. – 2008; 12 (2): 52–5 (in Russ.)].
- Sibireva O.F., Hitrinskaja E.Ju., Kaljuzhin V.V. i dr. Polimorfizm genov II, V faktorov svertyvanija krovi i metilentetragidrofolatreduktazy u bol'nyh s diabeticheskoj nefropatiej: rasprostranennost', klinicheskoe i prognosticheskoe znachenie // Saharnyj diabet. – 2010; 1: 6–9 [Sibireva O.F., Hitrinskaja E.Ju., Kaljuzhin V.V. et al. Polymorphism of II and V genes of coagulation factors and methylene tetrahydrofolate reductase in patients with diabetic nephropathy: prevalence, clinical and prognostic significance // Sakharnyi diabet. – 2010; 1: 6–9 (in Russ.)].
- Sibireva O.F., Kaljuzhin V.V., Urazova O.I. i dr. Biohimicheskie markery disfunktsii endotelija u patsientov s diabeticheskoj nefropatiej // Klinicheskaja laboratornaja diagnostika. – 2012; 8: 8–11 [Sibireva O.F., Kaljuzhin V.V., Urazova O.I. et al. Biochemical markers of endothelial dysfunction in patients with diabetic nephropathy // Klinicheskaja laboratornaja diagnostika. – 2012; 8: 8–11 (in Russ.)].
- Tareev E.M. Klinicheskie varianty hronicheskogo glomerulonefrita. Nefrologija: rukovodstvo dlja vrachej v 2 t. Pod red. I.E. Tareevoj / M.: Meditsina, 1995; T. 2: s. 60–4 [Tareev E.M. Clinical options for chronic glomerulonephritis. Nefrologija: rukovodstvo dlja vrachej v 2 t. Pod red. I.E. Tareevoj / M.: Meditsina, 1995; Vol 2: p. 60–4 (in Russ.)].
- Tareeva I.E. Mehanizmy progressirovanija glomerulonefrita // Ter. arh. – 1996; 6: 5–10 [Tareev E.M. Mechanisms of progression of glomerulonephritis // Ter. arh. – 1996; 6: 5–10 (in Russ.)].
- Buysschaert M., Gala J., Bessomo A. et al. S677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia // Original article. – 2004; 30 (4): 349–54.
- Cosmi B., Palareti G. Oral anticoagulant therapy in venous thromboembolism // Semin. Vase. Med. – 2003; 3: 303–14.
- Fodinger M., Mannhalter C., Wolfl G. et al. Mutation (677 S to T) in the methyltetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients // Kidney Int. – 1997; 52 (2): 517–23.
- Franchi F., Cetin I., Todros T. et al. Intrauterine growth restriction and genetic predisposition to thrombophilia // Haematologica. – 2004; 89: 444–9. 14.
- Bostom A., Culleton B. Hyperhomocysteinemia in chronic renal disease // J. Am.Soc. Nephrol. – 1999; 10: 891–900.
- Ksiazek P., Bednarek-Skublewska A., Buraczynska M. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus // Med. Sci. Monit. – 2004; 10 (2): 47–51.
- Lorenzo D. 5,10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies // A HuGE Review: U.S.A. – 2000; 151 (9): 862–77.
- Middeldorp S., Meinardi J., Maria M. et al. The incidence of venous thromboembolism in relatives of patients with the prothrombin 20210A mutation // CHAPTER. – 2000; 3: 35–45.
- Moczulski D., Fojcik H., Zukowska-Szczechowska E. et al. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy // Nephrol. Dial. Transplant. – 2003; 18: 1535–40.
- Rosenberg N., Murata M., Ikeda Y. et al. The Frequent 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphism Is Associated with a Common Haplotype in Whites, Japanese, and Africans // Am. J. Hum. Genet. – 2002; 70: 758–62.